Shining Wang

702 total citations
44 papers, 441 citations indexed

About

Shining Wang is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Shining Wang has authored 44 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Genetics. Recurrent topics in Shining Wang's work include Chronic Lymphocytic Leukemia Research (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Shining Wang is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Shining Wang collaborates with scholars based in United States, China and Taiwan. Shining Wang's co-authors include Bai‐Ou Guan, James M. Gallo, Qingyu Zhou, Cheng‐Yen Kao, Ping Guo, Grace Chen, Xiaomin Wang, Yuanyuan Chen, Hélène M. Faessel and Cong Pian and has published in prestigious journals such as Journal of Clinical Oncology, Blood and ACS Applied Materials & Interfaces.

In The Last Decade

Shining Wang

38 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shining Wang United States 13 116 69 61 54 54 44 441
Bo Meng China 15 278 2.4× 33 0.5× 64 1.0× 51 0.9× 92 1.7× 68 726
Yanzhu Chen China 15 104 0.9× 62 0.9× 22 0.4× 40 0.7× 47 0.9× 45 680
Lidan Zhang China 15 146 1.3× 98 1.4× 28 0.5× 14 0.3× 39 0.7× 36 659
Siying Chen China 14 188 1.6× 130 1.9× 38 0.6× 22 0.4× 9 0.2× 47 531
Yue Zhong China 11 130 1.1× 28 0.4× 26 0.4× 48 0.9× 34 0.6× 39 426
Miaomiao Tang China 11 159 1.4× 29 0.4× 8 0.1× 56 1.0× 52 1.0× 23 462
Masakazu Sato Japan 13 226 1.9× 49 0.7× 11 0.2× 51 0.9× 147 2.7× 90 943
Jie Lai China 10 152 1.3× 64 0.9× 14 0.2× 232 4.3× 110 2.0× 24 753
Cheng-Wei Chang Taiwan 17 260 2.2× 20 0.3× 19 0.3× 77 1.4× 41 0.8× 31 649

Countries citing papers authored by Shining Wang

Since Specialization
Citations

This map shows the geographic impact of Shining Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shining Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shining Wang more than expected).

Fields of papers citing papers by Shining Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shining Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shining Wang. The network helps show where Shining Wang may publish in the future.

Co-authorship network of co-authors of Shining Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Shining Wang. A scholar is included among the top collaborators of Shining Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shining Wang. Shining Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Luo, Ziming, Chi‐Yu Chen, Shining Wang, et al.. (2024). Tppp3 is a novel molecule for retinal ganglion cell identification and optic nerve regeneration. Acta Neuropathologica Communications. 12(1). 204–204. 1 indexed citations
3.
Wang, Shining, et al.. (2024). GDF-15 Attenuates the Epithelium–Mesenchymal Transition and Alleviates TGFβ2-Induced Lens Opacity. Translational Vision Science & Technology. 13(7). 2–2. 2 indexed citations
4.
Wang, Shining, et al.. (2024). Generating ESC-Derived RGCs for Cell Replacement Therapy. Methods in molecular biology. 2848. 187–196. 4 indexed citations
5.
Gao, Fengyu, et al.. (2023). Advances in photo-catalytic oxidation of NH3 over modified TiO2 catalysts: Reaction pathways, improvement strategy and promotion mechanism. Journal of environmental chemical engineering. 11(5). 110602–110602. 11 indexed citations
6.
Kim, Richard D., Alexis D. Leal, Aparna R. Parikh, et al.. (2023). A phase I, first-in-human study of TAK-164, an antibody–drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C. Cancer Chemotherapy and Pharmacology. 91(4). 291–300. 12 indexed citations
7.
Wang, Shining, et al.. (2023). The correlation between Th17/Treg immune dysregulation and the disease severity in chronic spontaneous urticaria patients. Immunity Inflammation and Disease. 11(7). e920–e920. 9 indexed citations
8.
Constantinescu, Cristian, Terry Brown, Shining Wang, et al.. (2023). Clinical Characterization of [18F]T-008, a Cholesterol 24-Hydroxylase PET Ligand: Dosimetry, Kinetic Modeling, Variability, and Soticlestat Occupancy. Journal of Nuclear Medicine. 64(12). 1972–1979. 2 indexed citations
9.
Gupta, Neeraj, Karen L. Reckamp, David Ross Camidge, et al.. (2022). Population pharmacokinetic and exposure‐response analyses from ALTA‐1L: Model‐based analyses supporting the brigatinib dose in ALK‐positive NSCLC. Clinical and Translational Science. 15(5). 1143–1154. 5 indexed citations
10.
Wang, Shining, et al.. (2022). The Role of Aldose Reductase in Beta-Amyloid-Induced Microglia Activation. International Journal of Molecular Sciences. 23(23). 15088–15088. 14 indexed citations
11.
Pratz, Keith W., Jason Kaplan, Moshe Levy, et al.. (2022). A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 inhibitor, in patients with relapsed/refractory acute myeloid leukemia. Haematologica. 108(3). 705–716. 10 indexed citations
12.
Wang, Shining, et al.. (2021). Safety, tolerability, pharmacokinetics, pharmacodynamics, bioavailability and food effect of single doses of soticlestat in healthy subjects. British Journal of Clinical Pharmacology. 87(11). 4354–4365. 22 indexed citations
13.
Kim, Richard D., James M. Cleary, Alexis D. Leal, et al.. (2021). A phase 1 study of TAK-164, an anti-guanylyl cyclase C (GCC) antibody-drug conjugate (ADC), in patients (pts) with advanced gastrointestinal (GI) cancers expressing GCC.. Journal of Clinical Oncology. 39(15_suppl). 3050–3050. 3 indexed citations
14.
15.
Chen, Grace, et al.. (2018). Effects of Intrinsic Factors on the Clinical Pharmacokinetics of Vortioxetine. Clinical Pharmacology in Drug Development. 7(8). 880–888. 9 indexed citations
16.
17.
Wang, Shining, et al.. (2013). A micro-machined optical fiber acoustic sensor based on Fabry-Pérot interferometer. 28. 167–169. 2 indexed citations
18.
Guan, Bai‐Ou & Shining Wang. (2010). Fiber Grating Laser Current Sensor Based on Magnetic Force. IEEE Photonics Technology Letters. 22(4). 230–232. 36 indexed citations
19.
Wang, Shining, Qingyu Zhou, & James M. Gallo. (2009). Demonstration of the equivalent pharmacokinetic/pharmacodynamic dosing strategy in a multiple-dose study of gefitinib. Molecular Cancer Therapeutics. 8(6). 1438–1447. 28 indexed citations
20.
Liu, Suwen, Clement Lee, Shining Wang, & Donghao Lu. (2006). A New Bioimaging Carrier for Fluorescent Quantum Dots: Phospholipid Nanoemulsion Mimicking Natural Lipoprotein Core. Drug Delivery. 13(2). 159–164. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bo Meng Breakdown of academic impact, for papers by Yanzhu Chen Breakdown of academic impact, for papers by Lidan Zhang Breakdown of academic impact, for papers by Siying Chen Breakdown of academic impact, for papers by Yue Zhong Breakdown of academic impact, for papers by Miaomiao Tang Breakdown of academic impact, for papers by Masakazu Sato Breakdown of academic impact, for papers by Jie Lai Breakdown of academic impact, for papers by Cheng-Wei Chang
Rankless by CCL
2026